There are 2789 resources available
1335P - Updated results from a phase I/II study of anlotinib plus docetaxel vs docetaxel as second-line treatment of advanced non-small cell lung cancer (NSCLC)
Presenter: Yong Fang
Session: ePoster Display
1337P - Clinical study of apatinib combined with radiation therapy in advanced non-small cell lung cancer patients with brain metastasis
Presenter: Xiaqin Zhang
Session: ePoster Display
1338P - A phase III study comparing BCD-021, a bevacizumab biosimilar, and reference bevacizumab in patients with stage IIIB or IV non-squamous NSCLC
Presenter: Natalia Fadeeva
Session: ePoster Display
1340P - The characteristics of the intestinal flora of advanced non-small cell lung cancer in China and its role in chemotherapy based on metagenomics
Presenter: Xiangjun Liu
Session: ePoster Display
Resources:
Abstract
1438TiP - INTEGRATE IIb: A randomised phase III open label study of regorafenib + nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)
Presenter: Nick Pavlakis
Session: ePoster Display